The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.
Notice of Funding Opportunities
Title Sort ascending | Announcement Number | Activity Code | Clinical Trials Status | Expiration Date | Program Official |
---|---|---|---|---|---|
Cancer Prevention and Control Clinical Trials Grant Program | PAR-24-072 (R01 Clinical Trial Required) | R01 | Clinical Trial Required | 01/08/2027 | Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Cancer Immunoprevention Network (CIP-Net) Research Projects | RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed) | UH3, UG3 | 07/04/2024 | Altaf Mohammed, Ph.D. | |
Biology of Bladder Cancer | PAR-22-219 (R21 Clinical Trial Optional) | R21 | Clinical Trial Optional | 09/08/2025 | |
Biology of Bladder Cancer | PAR-22-218 (R01 Clinical Trial Optional) | R01 | Clinical Trial Optional | 09/08/2025 | |
Basic Research in Cancer Health Disparities | PAR-21-323 (R21 Clinical Trial Not Allowed) | R21 | Clinical Trial Not Allowed | 09/08/2024 | Asad Umar, D.V.M., Ph.D. |
Basic Research in Cancer Health Disparities | PAR-21-324 (R03 Clinical Trial Not Allowed) | R03 | Clinical Trial Not Allowed | 09/08/2024 | Asad Umar, D.V.M., Ph.D. |
Basic Research in Cancer Health Disparities | PAR-21-322 (R01 Clinical Trial Not Allowed) | R01 | Clinical Trial Not Allowed | 09/08/2024 | Asad Umar, D.V.M., Ph.D. |
Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-23-313 (UH2/UH3 Clinical Trial Not Allowed) | UH2, UH3 | Clinical Trial Not Allowed | 10/15/2026 | Sudhir Srivastava, Ph.D., M.P.H. |
Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-23-314 (UH3 Clinical Trials Not Allowed) | UH3 | 10/15/2026 | Sudhir Srivastava, Ph.D., M.P.H. | |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research | RFA-CA-24-009 (R33 Clinical Trial Not Allowed) | R33 | Clinical Trial Not Allowed | 10/02/2024 | Guillermo Marquez, Ph.D. |